文献速递脑血管病

出血性梗死不恶化非心源性缺血性卒中功能结局:PACIFIC-STROKE二次分析

Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKE.
PubMed 文献 · Stroke · 2025-04-08

本研究为PACIFIC-STROKE试验的二次分析,纳入1544例急性非心源性缺血性卒中患者,其中248例(16.1%)为HI 1型,189例(12.2%)为HI 2型。多变量logistic回归校正卒中严重程度、梗死体积等因素后,HI 1型(校正OR 1.05,95%CI 0.74-1.51)或HI 2型(校正OR 0.88,95%CI 0.57-1.34)与90天不良功能结局(mRS 2-6)无显著关联。

要点

  • 急性非心源性缺血性卒中患者中HI 1型占16.1%,HI 2型占12.2%。
  • HI 1型与90天不良功能结局无关(校正OR 1.05,95%CI 0.74-1.51)。
  • HI 2型与90天不良功能结局无关(校正OR 0.88,95%CI 0.57-1.34)。

核心结论

  • 急性非心源性缺血性卒中患者中,出血性梗死(HI)的存在未导致90天改良Rankin量表评分的不良功能结局。

研究设计与样本

  • 本研究为PACIFIC-STROKE试验(口服FXIa抑制剂BAY 2433334在急性非心源性卒中患者中的适当剂量与安全性)的二次分析。
  • 纳入接受阿森德西安或安慰剂联合指南抗血小板治疗的急性非心源性缺血性卒中患者,所有患者在卒中 onset 后120小时内接受脑MRI。
  • 经铁敏感序列检测的出血转化按海德堡出血分类为HI(H1和H2)者纳入分析,共1544例(平均年龄67岁,67%男性)。

主要发现

  • 从1745例有 adequate 基线脑MRI的患者中排除10例实质性出血和191例无mRS评分者,最终纳入1544例。
  • HI 1型248例(16.1%),HI 2型189例(12.2%),无HI组1107例。
  • 不良功能结局(90天mRS 2-6)比例:HI 1型27.4%(68/248),HI 2型25.9%(49/189),无HI组23.0%(255/1107)。
  • 多变量logistic回归校正卒中严重程度、梗死体积、铁敏感序列类型及其他协变量后,HI 1型(校正OR 1.05,95%CI 0.74-1.51)或HI 2型(校正OR 0.88,95%CI 0.57-1.34)与不良功能结局无显著关联。
  • 铁敏感序列类型未改变上述结果。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemorrhagic infarction (HI) of acute ischemic stroke is frequent. Whether radiologically detected HI affects stroke outcomes has been less explored. METHODS: This was a secondary analysis of the PACIFIC-STROKE trial (Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following Acute Noncardioembolic Stroke), which enrolled patients with acute noncardioembolic ischemic stroke receiving either asundexian or placebo in addition to guideline-based antiplatelet therapy. All patients received brain magnetic resonance imaging within 120 hours after stroke onset. Patients with hemorrhagic transformation detected on iron-sensitive sequences and classified as HI (H1 and H2) by the Heidelberg Bleeding Classification were included in the analysis. Primary outcome was poor functional outcome, defined by a modified Rankin Scale score of 2 to 6 at 90 days after stroke. RESULTS: From 1745 patients with adequate baseline brain magnetic resonance imaging (median, 47.8 hours; interquartile range, 28.2-69.4 hours after symptom onset), 10 with parenchymal hemorrhage and 191 without modified Rankin Scale score were excluded. Of the 1544 patients (mean age, 67 years; 67% male), 248 (16.1%) had HI type 1, and 189 (12.2%) had HI type 2. The proportion of patients with poor functional outcome was 27.4% (68/248) in HI type 1, 25.9% (49/189) in HI type 2, and 23.0% (255/1107) in no HI groups. In the multivariable logistic regression model adjusting for stroke severity, infarct size, type of iron-sensitive sequences used, and other covariates, the presence of HI type 1 (adjusted odds ratio, 1.05 [95% CI, 0.74-1.51]) or HI type 2 (adjusted odds ratio, 0.88 [95% CI, 0.57-1.34]) were not associated with poor functional outcome. Of note, the type of iron-sensitive sequences did not modify the results. CONCLUSIONS: The presence of HI did not lead to poor functional outcome on the modified Rankin Scale in patients with acute noncardioembolic ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chen CH, Shoamanesh A, Colorado P, et al. Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKE. Stroke. 2025. PMID: 40197044. doi:10.1161/STROKEAHA.124.049188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。